What is the equivalent dose of Solu‑Medrol (methylprednisolone) to Omnacortil (prednisolone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Equivalent Dose of Solu-Medrol to Omnacortil

Methylprednisolone (Solu-Medrol) is approximately 1.25 times more potent than prednisolone (Omnacortil), meaning 4 mg of methylprednisolone equals 5 mg of prednisolone. 1

Standard Conversion Ratio

  • The established conversion is 4 mg methylprednisolone = 5 mg prednisolone/prednisone, based on anti-inflammatory potency equivalence 1
  • Methylprednisolone is 5 times more potent than hydrocortisone, while prednisolone is 4 times more potent than hydrocortisone, yielding the 1.25:1 ratio 1
  • This ratio applies to both oral and intravenous formulations, as both drugs have excellent bioavailability 1

Practical Conversion Examples

  • Omnacortil 5 mg = Solu-Medrol 4 mg 1
  • Omnacortil 25 mg = Solu-Medrol 20 mg 1
  • Omnacortil 60 mg = Solu-Medrol 48 mg 1
  • Omnacortil 75 mg = Solu-Medrol 60 mg 2

Route-Specific Considerations

When Converting Oral to IV

  • The 1.25:1 ratio remains valid because both oral formulations have excellent bioavailability and rapid absorption 1
  • For grade 3-4 toxicities requiring IV therapy, administer IV methylprednisolone 1-2 mg/kg, which equals oral prednisone 1.25-2.5 mg/kg 1
  • IV methylprednisolone provides more rapid therapeutic effect and higher peak concentrations, making it preferred for severe disease flares 3

Transitioning from IV Pulse to Oral Maintenance

  • After IV methylprednisolone pulse therapy (500-1000 mg daily for 1-3 days), transition to oral prednisone at 0.5-1 mg/kg/day (maximum 60 mg/day) 2
  • Use the same 1:1.25 conversion ratio when switching from IV methylprednisolone to oral prednisolone 2
  • Taper oral prednisolone gradually over 3-6 months depending on clinical response 2

Pharmacokinetic Differences That Matter Clinically

  • Methylprednisolone exhibits linear, dose-independent pharmacokinetics, making dosing more predictable 4
  • Prednisolone shows marked dose-dependent pharmacokinetics with saturable protein binding, resulting in higher clearance at higher doses 4, 5
  • Methylprednisolone has 77% protein binding that is linear and non-saturable 5
  • Prednisolone binds to transcortin (corticosteroid-binding globulin), which becomes saturated at higher doses, complicating dose predictions 4, 5

Clinical Advantages of Each Agent

Methylprednisolone Advantages

  • More predictable pharmacokinetics because concentrations are proportional to dose without need for protein binding determination 4
  • Greater anti-inflammatory potency than prednisolone with less tendency to induce sodium and water retention 6
  • Preferred for pulse therapy in severe autoimmune conditions due to more rapid onset 7

Prednisolone Advantages

  • Oral formulation is widely available and less expensive
  • Suitable for maintenance therapy after initial pulse treatment 2

Common Pitfalls and Caveats

  • Do not confuse methylprednisolone with methylprednisone—they are different compounds 1
  • When converting from high-dose pulse therapy to oral maintenance, avoid underdosing by carefully applying the 1.25:1 ratio 2
  • Prednisolone's dose-dependent pharmacokinetics make it extremely difficult to determine the exact dose needed for a desired target concentration, especially at higher doses 4
  • Both agents require identical bone protection measures: calcium and vitamin D supplementation with bisphosphonates for patients taking prednisone ≥7.5 mg daily (or methylprednisolone ≥6 mg daily) for ≥3 months 1
  • Monitor blood glucose during conversion, especially when using higher doses, as hyperglycemic effects peak 6-9 hours post-administration 2

High-Dose Pulse Therapy Context

  • For pulse therapy, methylprednisolone 500-1000 mg IV daily for 1-3 days is standard for severe autoimmune conditions 2
  • The American College of Rheumatology defines high-dose pulse glucocorticoids as ≥10 mg/kg/day methylprednisolone equivalent 8
  • High-dose oral glucocorticoids are defined as ≥2 mg/kg/day prednisone equivalent 8
  • After pulse therapy, transition to oral prednisone 0.5-1 mg/kg/day using the conversion ratio 2

References

Guideline

Corticosteroid Conversion and Clinical Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pulse Methylprednisolone Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Oral to Intravenous Methylprednisolone Conversion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.